Ra Capital Management as of Sept. 30, 2013
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 33 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 20.9 | $200M | 7.3M | 27.47 | |
| Sangamo Biosciences (SGMO) | 8.0 | $76M | 7.3M | 10.49 | |
| Dyax | 7.8 | $75M | 11M | 6.86 | |
| Novavax | 6.8 | $66M | 21M | 3.15 | |
| Achillion Pharmaceuticals | 6.3 | $60M | 20M | 3.02 | |
| Therapeuticsmd | 5.0 | $48M | 17M | 2.93 | |
| Insmed (INSM) | 4.9 | $47M | 3.0M | 15.61 | |
| Newlink Genetics Corporation | 4.6 | $44M | 2.3M | 18.78 | |
| BioCryst Pharmaceuticals (BCRX) | 4.4 | $43M | 5.8M | 7.28 | |
| Keryx Biopharmaceuticals | 3.6 | $34M | 3.4M | 10.09 | |
| Prothena (PRTA) | 3.5 | $33M | 1.6M | 20.23 | |
| XOMA CORP Common equity shares | 3.2 | $31M | 6.9M | 4.49 | |
| Derma Sciences | 2.6 | $25M | 2.0M | 12.38 | |
| Sunesis Pharmaceuticals | 2.5 | $24M | 4.9M | 4.96 | |
| Hyperion Therapeutics | 2.5 | $24M | 903k | 26.13 | |
| Chemocentryx | 1.8 | $17M | 3.0M | 5.56 | |
| Bluebird Bio (BLUE) | 1.3 | $13M | 467k | 26.96 | |
| Rockwell Medical Technologies | 1.2 | $11M | 1.0M | 11.40 | |
| Myriad Genetics (MYGN) | 1.1 | $11M | 450k | 23.50 | |
| Omeros Corporation (OMER) | 1.1 | $10M | 1.1M | 9.75 | |
| Ampio Pharmaceuticals | 1.0 | $9.9M | 1.3M | 7.50 | |
| Enzo Biochem (ENZ) | 0.9 | $8.4M | 3.3M | 2.52 | |
| Mirati Therapeutics | 0.9 | $8.4M | 552k | 15.15 | |
| Dynavax Technologies Corporation | 0.8 | $7.1M | 6.0M | 1.19 | |
| OncoGenex Pharmaceuticals | 0.7 | $7.1M | 763k | 9.27 | |
| Coronado Biosciences Inc. Common | 0.7 | $7.0M | 1.0M | 7.01 | |
| Ptc Therapeutics I (PTCT) | 0.7 | $6.4M | 300k | 21.46 | |
| Arrowhead Research | 0.5 | $5.0M | 880k | 5.69 | |
| Tg Therapeutics (TGTX) | 0.3 | $3.0M | 600k | 5.04 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $2.0M | 70k | 27.96 | |
| Ocera Therapeutics | 0.2 | $1.8M | 216k | 8.47 | |
| Epizyme | 0.0 | $400k | 10k | 40.00 | |
| Savient Pharmaceuticals note | 0.0 | $190k | 1.0M | 0.19 |
